Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsubasa Miyazaki

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancers|December 30, 2025
Radiodynamic Therapy for High-Grade Glioma in Normoxic and Hypoxic Environments for High-Grade GliomaErika Yamada, Eiichi Ishikawa, Tsubasa Miyazaki, et al.
International Journal of Breast Cancer|March 27, 2018
Rate of Clinical Complete Response for 1 Year or More in Bone-Metastatic Breast Cancer after Comprehensive Treatments including Autologous Formalin-Fixed Tumor VaccineFumito Kuranishi, Yuki Imaoka, Yuusuke Sumi, et al.
Brain Tumor Pathology|January 26, 2020
Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cellsTsubasa Miyazaki, Eiichi Ishikawa, Masahide Matsuda, et al.
Journal of Neuro-Oncology|June 12, 2025
PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccineKazuki Akutagawa, Shunichiro Miki, Erika Yamada, et al.
Neuro-Oncology Advances|July 24, 2023
P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patientsErika Yamada, Eiichi Ishikawa, Tsubasa Miyazaki, et al.
Journal of Neuro-Oncology|April 28, 2017
Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcomeTsubasa Miyazaki, Eiichi Ishikawa, Masahide Matsuda, et al.
Clinical Breast Cancer|July 22, 2025
Thirty-Five-Year Follow-Up Real-World Data Revealed the Efficacy of Autologous Formalin-Fixed Tumor Vaccine on Metastatic Breast Cancer-A Target Trial EmulationFumito Kuranishi, Tsubasa Miyazaki, Tomohiko Tagashira, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|September 26, 2024
Development of a genotoxicity/carcinogenicity assessment method by DNA adductome analysisKohei Watanabe, Masami Komiya, Asuka Obikane, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancers|December 30, 2025
Radiodynamic Therapy for High-Grade Glioma in Normoxic and Hypoxic Environments for High-Grade GliomaErika Yamada, Eiichi Ishikawa, Tsubasa Miyazaki, et al.
International Journal of Breast Cancer|March 27, 2018
Rate of Clinical Complete Response for 1 Year or More in Bone-Metastatic Breast Cancer after Comprehensive Treatments including Autologous Formalin-Fixed Tumor VaccineFumito Kuranishi, Yuki Imaoka, Yuusuke Sumi, et al.
Brain Tumor Pathology|January 26, 2020
Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cellsTsubasa Miyazaki, Eiichi Ishikawa, Masahide Matsuda, et al.
Journal of Neuro-Oncology|June 12, 2025
PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccineKazuki Akutagawa, Shunichiro Miki, Erika Yamada, et al.
Neuro-Oncology Advances|July 24, 2023
P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patientsErika Yamada, Eiichi Ishikawa, Tsubasa Miyazaki, et al.
Journal of Neuro-Oncology|April 28, 2017
Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcomeTsubasa Miyazaki, Eiichi Ishikawa, Masahide Matsuda, et al.
Clinical Breast Cancer|July 22, 2025
Thirty-Five-Year Follow-Up Real-World Data Revealed the Efficacy of Autologous Formalin-Fixed Tumor Vaccine on Metastatic Breast Cancer-A Target Trial EmulationFumito Kuranishi, Tsubasa Miyazaki, Tomohiko Tagashira, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|September 26, 2024
Development of a genotoxicity/carcinogenicity assessment method by DNA adductome analysisKohei Watanabe, Masami Komiya, Asuka Obikane, et al.
Pageof 2